1. Home
  2. ATRA vs OKUR Comparison

ATRA vs OKUR Comparison

Compare ATRA & OKUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATRA
  • OKUR
  • Stock Information
  • Founded
  • ATRA 2012
  • OKUR 2011
  • Country
  • ATRA United States
  • OKUR United States
  • Employees
  • ATRA N/A
  • OKUR N/A
  • Industry
  • ATRA Biotechnology: Biological Products (No Diagnostic Substances)
  • OKUR
  • Sector
  • ATRA Health Care
  • OKUR
  • Exchange
  • ATRA Nasdaq
  • OKUR NYSE
  • Market Cap
  • ATRA 65.1M
  • OKUR 75.5M
  • IPO Year
  • ATRA 2014
  • OKUR N/A
  • Fundamental
  • Price
  • ATRA $9.44
  • OKUR $5.74
  • Analyst Decision
  • ATRA Buy
  • OKUR Strong Buy
  • Analyst Count
  • ATRA 6
  • OKUR 4
  • Target Price
  • ATRA $25.70
  • OKUR $35.00
  • AVG Volume (30 Days)
  • ATRA 436.6K
  • OKUR 135.4K
  • Earning Date
  • ATRA 03-27-2025
  • OKUR 02-14-2025
  • Dividend Yield
  • ATRA N/A
  • OKUR N/A
  • EPS Growth
  • ATRA N/A
  • OKUR N/A
  • EPS
  • ATRA N/A
  • OKUR N/A
  • Revenue
  • ATRA $100,439,000.00
  • OKUR N/A
  • Revenue This Year
  • ATRA $1,339.87
  • OKUR N/A
  • Revenue Next Year
  • ATRA N/A
  • OKUR N/A
  • P/E Ratio
  • ATRA N/A
  • OKUR N/A
  • Revenue Growth
  • ATRA 2111.34
  • OKUR N/A
  • 52 Week Low
  • ATRA $5.40
  • OKUR $4.58
  • 52 Week High
  • ATRA $28.75
  • OKUR $20.00
  • Technical
  • Relative Strength Index (RSI)
  • ATRA 44.94
  • OKUR N/A
  • Support Level
  • ATRA $8.02
  • OKUR N/A
  • Resistance Level
  • ATRA $9.10
  • OKUR N/A
  • Average True Range (ATR)
  • ATRA 1.12
  • OKUR 0.00
  • MACD
  • ATRA -0.02
  • OKUR 0.00
  • Stochastic Oscillator
  • ATRA 45.13
  • OKUR 0.00

About ATRA Atara Biotherapeutics Inc.

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).

About OKUR ONKURE THERAPEUTICS INC

OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing top-tier precision medicines that target biologically validated drivers of cancers that are underserved by available therapies. It has a pipeline of tumor-agnostic candidates that are designed to achieve optimal efficacy and tolerability.

Share on Social Networks: